메뉴 건너뛰기




Volumn 35, Issue 5, 2013, Pages 448-456

Pharmaco-proteomics opportunities for individualizing neurovascular treatment

Author keywords

Cardiac arrest; Patent foramen ovale (PFO) related stroke; Proteomics; Therapeutic hypothermia; Thrombolysis

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

EID: 84878273363     PISSN: 01616412     EISSN: 17431328     Source Type: Journal    
DOI: 10.1179/1743132813Y.0000000213     Document Type: Review
Times cited : (11)

References (138)
  • 1
    • 84984763363 scopus 로고    scopus 로고
    • Mechanisms, challenges and opportunities in stroke
    • Lo EH, Dalkara T, Moskowitz MA. Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci. 2003;4(5):399-415.
    • (2003) Nat Rev Neurosci. , vol.4 , Issue.5 , pp. 399-415
    • Lo, E.H.1    Dalkara, T.2    Moskowitz, M.A.3
  • 2
    • 33745141581 scopus 로고    scopus 로고
    • Recommendations of the National Heart, Lung, and Blood Institute working group on cerebrovascular biology and disease
    • Iadecola C, Goldman SS, Harder DR, Heistad DD, Katusic ZS, Moskowitz MA, et al. Recommendations of the National Heart, Lung, and Blood Institute working group on cerebrovascular biology and disease. Stroke. 2006;37(6):1578-81.
    • (2006) Stroke. , vol.37 , Issue.6 , pp. 1578-1581
    • Iadecola, C.1    Goldman, S.S.2    Harder, D.R.3    Heistad, D.D.4    Katusic, Z.S.5    Moskowitz, M.A.6
  • 3
    • 0028783948 scopus 로고
    • Tissue plasminogen activator for acute ischemic stroke
    • The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group
    • The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333(24):1581-7.
    • (1995) N Engl J Med. , vol.333 , Issue.24 , pp. 1581-1587
  • 4
    • 0034888230 scopus 로고    scopus 로고
    • Treatment with tissue plasminogen activator and inpatient mortality rates for patients with ischemic stroke treated in community hospitals
    • Reed SD, Cramer SC, Blough DK, Meyer K, Jarvik JG. Treatment with tissue plasminogen activator and inpatient mortality rates for patients with ischemic stroke treated in community hospitals. Stroke. 2001;32(8):1832-40.
    • (2001) Stroke. , vol.32 , Issue.8 , pp. 1832-1840
    • Reed, S.D.1    Cramer, S.C.2    Blough, D.K.3    Meyer, K.4    Jarvik, J.G.5
  • 5
    • 0141889869 scopus 로고    scopus 로고
    • Sustained benefit of a community and professional intervention to increase acute stroke therapy
    • Morgenstern LB, Bartholomew LK, Grotta JC, Staub L, King M, Chan W. Sustained benefit of a community and professional intervention to increase acute stroke therapy. Arch Intern Med. 2003;163(18):2198-202.
    • (2003) Arch Intern Med. , vol.163 , Issue.18 , pp. 2198-2202
    • Morgenstern, L.B.1    Bartholomew, L.K.2    Grotta, J.C.3    Staub, L.4    King, M.5    Chan, W.6
  • 6
    • 1542315556 scopus 로고    scopus 로고
    • Association of outcome with early stroke treatment: Pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials
    • Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004;363(9411):768-74.
    • (2004) Lancet. , vol.363 , Issue.9411 , pp. 768-774
    • Hacke, W.1    Donnan, G.2    Fieschi, C.3    Kaste, M.4    von Kummer, R.5    Broderick, J.P.6
  • 7
    • 52649165720 scopus 로고    scopus 로고
    • Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke
    • Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359(13):1317-29.
    • (2008) N Engl J Med. , vol.359 , Issue.13 , pp. 1317-1329
    • Hacke, W.1    Kaste, M.2    Bluhmki, E.3    Brozman, M.4    Dávalos, A.5    Guidetti, D.6
  • 8
    • 77952112006 scopus 로고    scopus 로고
    • Time to treatment with intravenous alteplase and outcome in stroke: An updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials
    • Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet. 2010; 375(9727):1695-703.
    • (2010) Lancet. , vol.375 , Issue.9727 , pp. 1695-1703
    • Lees, K.R.1    Bluhmki, E.2    von Kummer, R.3    Brott, T.G.4    Toni, D.5    Grotta, J.C.6
  • 9
    • 71849095831 scopus 로고    scopus 로고
    • Stroke treatment with alteplase given 3.0-4.5 h after onset of acute ischaemic stroke (ECASS III): Additional outcomes and subgroup analysis of a randomised controlled trial
    • Bluhmki E, Chamorro A, Davalos A, Machnig T, Sauce C, Wahlgren N, et al. Stroke treatment with alteplase given 3.0-4.5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial. Lancet Neurol. 2009;8(12):1095-102.
    • (2009) Lancet Neurol. , vol.8 , Issue.12 , pp. 1095-1102
    • Bluhmki, E.1    Chamorro, A.2    Davalos, A.3    McHnig, T.4    Sauce, C.5    Wahlgren, N.6
  • 10
    • 0027314366 scopus 로고
    • Variability in resuscitation rates for out-of-hospital cardiac arrest
    • Cobb LA. Variability in resuscitation rates for out-of-hospital cardiac arrest. Arch Intern Med. 1993;153(10):1165-6.
    • (1993) Arch Intern Med. , vol.153 , Issue.10 , pp. 1165-1166
    • Cobb, L.A.1
  • 11
    • 0038163876 scopus 로고    scopus 로고
    • Therapeutic hypothermia after cardiac arrest: An advisory statement by the advanced life support task force of the International Liaison Committee on Resuscitation
    • Nolan JP, Morley PT, Vanden Hoek TL, Hickey RW, Kloeck WG, Billi J, et al. Therapeutic hypothermia after cardiac arrest: an advisory statement by the advanced life support task force of the International Liaison Committee on Resuscitation. Circulation. 2003;108(1):118-21.
    • (2003) Circulation. , vol.108 , Issue.1 , pp. 118-121
    • Nolan, J.P.1    Morley, P.T.2    Vanden Hoek, T.L.3    Hickey, R.W.4    Kloeck, W.G.5    Billi, J.6
  • 13
    • 29944442726 scopus 로고    scopus 로고
    • First documented rhythm and clinical outcome from in-hospital cardiac arrest among children and adults
    • Nadkarni VM, Larkin GL, Peberdy MA, Carey SM, Kaye W, Mancini ME, et al. First documented rhythm and clinical outcome from in-hospital cardiac arrest among children and adults. JAMA. 2006;295(1):50-7.
    • (2006) JAMA. , vol.295 , Issue.1 , pp. 50-57
    • Nadkarni, V.M.1    Larkin, G.L.2    Peberdy, M.A.3    Carey, S.M.4    Kaye, W.5    Mancini, M.E.6
  • 14
    • 0042829280 scopus 로고    scopus 로고
    • Cardiopulmonary resuscitation of adults in the hospital: A report of 14720 cardiac arrests from the National Registry of Cardiopulmonary Resuscitation
    • Peberdy MA, Kaye W, Ornato JP, Larkin GL, Nadkarni V, Mancini ME, et al. Cardiopulmonary resuscitation of adults in the hospital: a report of 14720 cardiac arrests from the National Registry of Cardiopulmonary Resuscitation. Resuscitation. 2003;58(3):297-308.
    • (2003) Resuscitation. , vol.58 , Issue.3 , pp. 297-308
    • Peberdy, M.A.1    Kaye, W.2    Ornato, J.P.3    Larkin, G.L.4    Nadkarni, V.5    Mancini, M.E.6
  • 15
    • 0033916173 scopus 로고    scopus 로고
    • Experiences from treatment of out-ofhospital cardiac arrest during 17 years in Goteborg
    • Herlitz J, Andersson E, Bang A, Engdahl J, Holmberg M, lindqvist J, et al. Experiences from treatment of out-ofhospital cardiac arrest during 17 years in Goteborg. Eur Heart J. 2000;21(15):1251-8.
    • (2000) Eur Heart J. , vol.21 , Issue.15 , pp. 1251-1258
    • Herlitz, J.1    Andersson, E.2    Bang, A.3    Engdahl, J.4    Holmberg, M.5    lindqvist, J.6
  • 16
    • 0029952473 scopus 로고    scopus 로고
    • Cost-effectiveness analysis of potential improvements to emergency medical services for victims of out-of-hospital cardiac arrest
    • Nichol G, Laupacis A, Stiell IG, O'Rourke K, Anis A, Bolley H, et al. Cost-effectiveness analysis of potential improvements to emergency medical services for victims of out-of-hospital cardiac arrest. Ann Emerg Med. 1996;27(6):711-20.
    • (1996) Ann Emerg Med. , vol.27 , Issue.6 , pp. 711-720
    • Nichol, G.1    Laupacis, A.2    Stiell, I.G.3    O'Rourke, K.4    Anis, A.5    Bolley, H.6
  • 17
    • 17844380263 scopus 로고    scopus 로고
    • Cardiac Arrest Resuscitation Evaluation in Los Angeles: CARE-LA
    • Eckstein M, Stratton SJ, Chan LS. Cardiac Arrest Resuscitation Evaluation in Los Angeles: CARE-LA. Ann Emerg Med. 2005;45(5):504-9.
    • (2005) Ann Emerg Med. , vol.45 , Issue.5 , pp. 504-509
    • Eckstein, M.1    Stratton, S.J.2    Chan, L.S.3
  • 18
    • 78649489733 scopus 로고    scopus 로고
    • Opportunities and challenges in Omics
    • Ning M, Lo EH. Opportunities and challenges in Omics. Transl Stroke Res. 2010;1(4):233-237.
    • (2010) Transl Stroke Res. , vol.1 , Issue.4 , pp. 233-237
    • Ning, M.1    Lo, E.H.2
  • 19
    • 81055124249 scopus 로고    scopus 로고
    • Pharmacoproteomics and toxicoproteomics: The field of dreams
    • Yu LR. Pharmacoproteomics and toxicoproteomics: the field of dreams. J Proteomics. 2011;74(12):2549-53.
    • (2011) J Proteomics. , vol.74 , Issue.12 , pp. 2549-2553
    • Yu, L.R.1
  • 20
    • 0036158585 scopus 로고    scopus 로고
    • ATLANTIS trial: Results for patients treated within 3 hours of stroke onset. Alteplase thrombolysis for acute noninterventional therapy in ischemic stroke
    • Albers GW, Clark WM, Madden KP, Hamilton SA. ATLANTIS trial: results for patients treated within 3 hours of stroke onset. Alteplase thrombolysis for acute noninterventional therapy in ischemic stroke. Stroke. 2002;33(2):493-5.
    • (2002) Stroke. , vol.33 , Issue.2 , pp. 493-495
    • Albers, G.W.1    Clark, W.M.2    Madden, K.P.3    Hamilton, S.A.4
  • 21
    • 0034161611 scopus 로고    scopus 로고
    • Use of tissue-type plasminogen activator for acute ischemic stroke: The Cleveland area experience
    • Katzan IL, Furlan AJ, Lloyd LE, Frank JI, Harper DL, Hinchey JA, et al. Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience. JAMA. 2000;283(9):1151-8.
    • (2000) JAMA. , vol.283 , Issue.9 , pp. 1151-1158
    • Katzan, I.L.1    Furlan, A.J.2    Lloyd, L.E.3    Frank, J.I.4    Harper, D.L.5    Hinchey, J.A.6
  • 22
    • 0034870972 scopus 로고    scopus 로고
    • Methodology for the Canadian activase for stroke effectiveness study (CASES). CASES investigators
    • Hill MD, Buchan AM. Methodology for the Canadian activase for stroke effectiveness study (CASES). CASES investigators. Can J Neurol Sci. 2001;28(3):232-8.
    • (2001) Can J Neurol Sci. , vol.28 , Issue.3 , pp. 232-238
    • Hill, M.D.1    Buchan, A.M.2
  • 23
    • 0033595255 scopus 로고    scopus 로고
    • Initial clinical experience with IV tissue plasminogen activator for acute ischemic stroke: A multicenter survey. The t-PA Stroke Survey Group
    • Tanne D, Bates VE, Verro P, Kasner SE, Binder JR, Patel SC, et al. Initial clinical experience with IV tissue plasminogen activator for acute ischemic stroke: a multicenter survey. The t-PA Stroke Survey Group. Neurology. 1999;53(2):424-7.
    • (1999) Neurology. , vol.53 , Issue.2 , pp. 424-427
    • Tanne, D.1    Bates, V.E.2    Verro, P.3    Kasner, S.E.4    Binder, J.R.5    Patel, S.C.6
  • 24
    • 80051570952 scopus 로고    scopus 로고
    • Protective effect of mild hypothermia on astrocytes with traumatic or ischemic injury
    • Cao Q, Zhang LL, Hu ZY, Wu BY. Protective effect of mild hypothermia on astrocytes with traumatic or ischemic injury. Nan Fang Yi Ke Da Xue Xue Bao. 2010;30(1):61-3.
    • (2010) Nan Fang Yi Ke Da Xue Xue Bao. , vol.30 , Issue.1 , pp. 61-63
    • Cao, Q.1    Zhang, L.L.2    Hu, Z.Y.3    Wu, B.Y.4
  • 25
    • 0033485522 scopus 로고    scopus 로고
    • Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: A randomized controlled trial. Alteplase thrombolysis for acute noninterventional therapy in ischemic stroke
    • Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase thrombolysis for acute noninterventional therapy in ischemic stroke. JAMA. 1999;282(21):2019-26.
    • (1999) JAMA. , vol.282 , Issue.21 , pp. 2019-2026
    • Clark, W.M.1    Wissman, S.2    Albers, G.W.3    Jhamandas, J.H.4    Madden, K.P.5    Hamilton, S.6
  • 26
    • 0028836677 scopus 로고
    • Termination of trial of streptokinase in severe acute ischaemic stroke. MAST Study Group
    • Hommel M, Boissel JP, Cornu C, Boutitie F, Lees KR, Besson G, et al. Termination of trial of streptokinase in severe acute ischaemic stroke. MAST Study Group. Lancet. 1995; 345(8941):57.
    • (1995) Lancet. , vol.345 , Issue.8941 , pp. 57
    • Hommel, M.1    Boissel, J.P.2    Cornu, C.3    Boutitie, F.4    Lees, K.R.5    Besson, G.6
  • 27
    • 0029042774 scopus 로고
    • Streptokinase in acute ischaemic stroke. Steering committees of the ASK and MAST-E trials. Australian streptokinase trial
    • Donnan GA, Hommel M, Davis SM, McNeil JJ. Streptokinase in acute ischaemic stroke. Steering committees of the ASK and MAST-E trials. Australian streptokinase trial. Lancet. 1995;346(8966):56.
    • (1995) Lancet. , vol.346 , Issue.8966 , pp. 56
    • Donnan, G.A.1    Hommel, M.2    Davis, S.M.3    McNeil, J.J.4
  • 28
    • 40949161352 scopus 로고    scopus 로고
    • Effects of alteplase beyond 3 h after stroke in the Echoplanar imaging thrombolytic evaluation trial (EPITHET): A placebo-controlled randomised trial
    • Davis SM, Donnan GA, Parsons MW, Levi C, Butcher KS, Peeters A, et al. Effects of alteplase beyond 3 h after stroke in the Echoplanar imaging thrombolytic evaluation trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol. 2008;7(4):299-309.
    • (2008) Lancet Neurol. , vol.7 , Issue.4 , pp. 299-309
    • Davis, S.M.1    Donnan, G.A.2    Parsons, M.W.3    Levi, C.4    Butcher, K.S.5    Peeters, A.6
  • 29
    • 70350653552 scopus 로고    scopus 로고
    • Baseline diabetic status and admission blood glucose were poor prognostic factors in the EPITHET trial
    • De Silva DA, Ebinger M, Christensen S, Parsons MW, Levi C, Butcher K, et al. Baseline diabetic status and admission blood glucose were poor prognostic factors in the EPITHET trial. Cerebrovasc Dis. 2010;29(1):14-21.
    • (2010) Cerebrovasc Dis. , vol.29 , Issue.1 , pp. 14-21
    • de Silva, D.A.1    Ebinger, M.2    Christensen, S.3    Parsons, M.W.4    Levi, C.5    Butcher, K.6
  • 30
    • 74049125986 scopus 로고    scopus 로고
    • Postthrombolysis blood pressure elevation is associated with hemorrhagic transformation
    • Butcher K, Christensen S, Parsons M, De Silva DA, Ebinger M, Levi C, et al. Postthrombolysis blood pressure elevation is associated with hemorrhagic transformation. Stroke. 2010; 41(1):72-7.
    • (2010) Stroke. , vol.41 , Issue.1 , pp. 72-77
    • Butcher, K.1    Christensen, S.2    Parsons, M.3    de Silva, D.A.4    Ebinger, M.5    Levi, C.6
  • 31
    • 77449158703 scopus 로고    scopus 로고
    • The benefits of intravenous thrombolysis relate to the site of baseline arterial occlusion in the echoplanar imaging thrombolytic evaluation trial (EPITHET)
    • De Silva DA, Brekenfeld C, Ebinger M, Christensen S, Barber PA, Butcher KS, et al. The benefits of intravenous thrombolysis relate to the site of baseline arterial occlusion in the echoplanar imaging thrombolytic evaluation trial (EPITHET). Stroke. 2010;41(2):295-9.
    • (2010) Stroke. , vol.41 , Issue.2 , pp. 295-299
    • de Silva, D.A.1    Brekenfeld, C.2    Ebinger, M.3    Christensen, S.4    Barber, P.A.5    Butcher, K.S.6
  • 32
    • 67650094822 scopus 로고    scopus 로고
    • Clinical-diffusion mismatch and benefit from thrombolysis 3 to 6 hours after acute stroke
    • Ebinger M, Iwanaga T, Prosser JF, De Silva DA, Christensen S, Collins M, et al. Clinical-diffusion mismatch and benefit from thrombolysis 3 to 6 hours after acute stroke. Stroke. 2009;40(7):2572-4.
    • (2009) Stroke. , vol.40 , Issue.7 , pp. 2572-2574
    • Ebinger, M.1    Iwanaga, T.2    Prosser, J.F.3    de Silva, D.A.4    Christensen, S.5    Collins, M.6
  • 33
    • 77953589787 scopus 로고    scopus 로고
    • Analysis of the national institute of neurological disorders and stroke tissue plasminogen activator studies following European cooperative acute stroke study III patient selection criteria
    • Hemmen TM, Rapp KS, Emond JA, Raman R, Lyden PD. Analysis of the national institute of neurological disorders and stroke tissue plasminogen activator studies following European cooperative acute stroke study III patient selection criteria. J Stroke Cerebrovasc Dis. 2010;19(4):290-3.
    • (2010) J Stroke Cerebrovasc Dis. , vol.19 , Issue.4 , pp. 290-293
    • Hemmen, T.M.1    Rapp, K.S.2    Emond, J.A.3    Raman, R.4    Lyden, P.D.5
  • 34
    • 0037224938 scopus 로고    scopus 로고
    • Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke
    • Castellanos M, Leira R, Serena J, Pumar JM, Lizasoain I, Castillo J, et al. Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke. Stroke. 2003;34(1):40-6.
    • (2003) Stroke. , vol.34 , Issue.1 , pp. 40-46
    • Castellanos, M.1    Leira, R.2    Serena, J.3    Pumar, J.M.4    Lizasoain, I.5    Castillo, J.6
  • 35
    • 0036284568 scopus 로고    scopus 로고
    • Thrombolysis-related hemorrhagic infarction: A marker of early reperfusion, reduced infarct size, and improved outcome in patients with proximal middle cerebral artery occlusion
    • Molina CA, Alvarez-Sabin J, Montaner J, Abilleira S, Arenillas JF, Coscojuela P, et al. Thrombolysis-related hemorrhagic infarction: a marker of early reperfusion, reduced infarct size, and improved outcome in patients with proximal middle cerebral artery occlusion. Stroke. 2002;33(6):1551-6.
    • (2002) Stroke. , vol.33 , Issue.6 , pp. 1551-1556
    • Molina, C.A.1    Alvarez-Sabin, J.2    Montaner, J.3    Abilleira, S.4    Arenillas, J.F.5    Coscojuela, P.6
  • 36
    • 0037418038 scopus 로고    scopus 로고
    • Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke
    • Montaner J, Molina CA, Monasterio J, Abilleira S, Arenillas JF, Ribó M, et al. Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke. Circulation. 2003;107(4):598-603.
    • (2003) Circulation. , vol.107 , Issue.4 , pp. 598-603
    • Montaner, J.1    Molina, C.A.2    Monasterio, J.3    Abilleira, S.4    Arenillas, J.F.5    Ribó, M.6
  • 38
    • 0034893137 scopus 로고    scopus 로고
    • Matrix metalloproteinase expression after human cardioembolic stroke: Temporal profile and relation to neurological impairment
    • Montaner J, Alvarez-Sabin J, Molina C, Anglés A, Abilleira S, Arenillas J, et al. Matrix metalloproteinase expression after human cardioembolic stroke: temporal profile and relation to neurological impairment. Stroke. 2001;32(8):1759-66.
    • (2001) Stroke. , vol.32 , Issue.8 , pp. 1759-1766
    • Montaner, J.1    Alvarez-Sabin, J.2    Molina, C.3    Anglés, A.4    Abilleira, S.5    Arenillas, J.6
  • 39
    • 0035478029 scopus 로고    scopus 로고
    • Effects of matrix metalloproteinase-9 gene knockout on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia
    • Asahi M, Wang X, Mori T, Sumii T, Jung JC, Moskowitz MA, et al. Effects of matrix metalloproteinase-9 gene knockout on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J Neurosci. 2001; 21(19):7724-32.
    • (2001) J Neurosci. , vol.21 , Issue.19 , pp. 7724-7732
    • Asahi, M.1    Wang, X.2    Mori, T.3    Sumii, T.4    Jung, J.C.5    Moskowitz, M.A.6
  • 40
    • 66049149650 scopus 로고    scopus 로고
    • T-PA-mediated increase in matrix metalloproteinase-9 in acute ischemic stroke is independent of inflammatory response
    • Ning MM, Lo EH, Furie KL, Koroshetz WJ, Sleeper L, Wang XY, et al. T-PA-mediated increase in matrix metalloproteinase-9 in acute ischemic stroke is independent of inflammatory response. Stroke. 2004;35(1):298.
    • (2004) Stroke. , vol.35 , Issue.1 , pp. 298
    • Ning, M.M.1    Lo, E.H.2    Furie, K.L.3    Koroshetz, W.J.4    Sleeper, L.5    Wang, X.Y.6
  • 42
    • 0042623437 scopus 로고    scopus 로고
    • Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion
    • Pfefferkorn T, Rosenberg GA. Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion. Stroke. 2003;34(8):2025-30.
    • (2003) Stroke. , vol.34 , Issue.8 , pp. 2025-2030
    • Pfefferkorn, T.1    Rosenberg, G.A.2
  • 43
    • 0033581392 scopus 로고    scopus 로고
    • Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion
    • Fujimura M, Gasche Y, Morita-Fujimura Y, Massengale J, Kawase M, Chan PH. Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion. Brain Res. 1999;842(1):92-100.
    • (1999) Brain Res. , vol.842 , Issue.1 , pp. 92-100
    • Fujimura, M.1    Gasche, Y.2    Morita-Fujimura, Y.3    Massengale, J.4    Kawase, M.5    Chan, P.H.6
  • 44
    • 0029959730 scopus 로고    scopus 로고
    • Hemorrhagic transformation and microvascular integrity during focal cerebral ischemia/reperfusion
    • Hamann GF, Okada Y, del Zoppo GJ. Hemorrhagic transformation and microvascular integrity during focal cerebral ischemia/reperfusion. J Cereb Blood Flow Metab. 1996;16(6):1373-8.
    • (1996) J Cereb Blood Flow Metab. , vol.16 , Issue.6 , pp. 1373-1378
    • Hamann, G.F.1    Okada, Y.2    del Zoppo, G.J.3
  • 45
    • 0033666754 scopus 로고    scopus 로고
    • Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke
    • Lapchak PA, Chapman DF, Zivin JA. Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke. Stroke. 2000;31(12):3034-40.
    • (2000) Stroke. , vol.31 , Issue.12 , pp. 3034-3040
    • Lapchak, P.A.1    Chapman, D.F.2    Zivin, J.A.3
  • 46
    • 0034992131 scopus 로고    scopus 로고
    • Rapid differential endogenous plasminogen activator expression after acute middle cerebral artery occlusion
    • Hosomi N, Lucero J, Heo JH, Koziol JA, Copeland BR, del Zoppo GJ. Rapid differential endogenous plasminogen activator expression after acute middle cerebral artery occlusion. Stroke. 2001;32(6):1341-8.
    • (2001) Stroke. , vol.32 , Issue.6 , pp. 1341-1348
    • Hosomi, N.1    Lucero, J.2    Heo, J.H.3    Koziol, J.A.4    Copeland, B.R.5    del Zoppo, G.J.6
  • 47
    • 43249116466 scopus 로고    scopus 로고
    • A new penumbra: Transitioning from injury into repair after stroke
    • Lo EH. A new penumbra: transitioning from injury into repair after stroke. Nat Med. 2008;14(5):497-500.
    • (2008) Nat Med. , vol.14 , Issue.5 , pp. 497-500
    • Lo, E.H.1
  • 48
    • 0842289222 scopus 로고    scopus 로고
    • tPA and proteolysis in the neurovascular unit
    • Lo EH, Broderick JP, Moskowitz MA. tPA and proteolysis in the neurovascular unit. Stroke. 2004;35(2):354-6.
    • (2004) Stroke. , vol.35 , Issue.2 , pp. 354-356
    • Lo, E.H.1    Broderick, J.P.2    Moskowitz, M.A.3
  • 49
    • 62949092903 scopus 로고    scopus 로고
    • The neurovascular unit in health and disease: Introduction
    • Lo EH, Rosenberg GA. The neurovascular unit in health and disease: introduction. Stroke. 2009;40(Suppl.3):S2-3.
    • (2009) Stroke. , vol.40 , Issue.SUPPL. 3
    • Lo, E.H.1    Rosenberg, G.A.2
  • 50
    • 84867072741 scopus 로고    scopus 로고
    • Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): A randomised, parallel-group, non-inferiority trial
    • Saver JL, Jahan R, Levy EI, Jovin TG, Baxter B, Nogueira RG, et al. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet. 2012;380(9849):1241-9.
    • (2012) Lancet. , vol.380 , Issue.9849 , pp. 1241-1249
    • Saver, J.L.1    Jahan, R.2    Levy, E.I.3    Jovin, T.G.4    Baxter, B.5    Nogueira, R.G.6
  • 51
    • 0036302814 scopus 로고    scopus 로고
    • Protease degradomics: A new challenge for proteomics
    • Lopez-Otin C, Overall CM. Protease degradomics: a new challenge for proteomics. Nat Rev Mol Cell Biol. 2002; 3(7):509-19.
    • (2002) Nat Rev Mol Cell Biol. , vol.3 , Issue.7 , pp. 509-519
    • Lopez-Otin, C.1    Overall, C.M.2
  • 52
    • 0242653640 scopus 로고    scopus 로고
    • Clinical proteomics: Written in blood
    • Liotta LA, Ferrari M, Petricoin E. Clinical proteomics: written in blood. Nature. 2003;425(6961):905.
    • (2003) Nature. , vol.425 , Issue.6961 , pp. 905
    • Liotta, L.A.1    Ferrari, M.2    Petricoin, E.3
  • 53
    • 67449115771 scopus 로고    scopus 로고
    • Neuroproteomics and systems biology-based discovery of protein biomarkers for traumatic brain injury and clinical validation
    • Kobeissy FH, Sadasivan S, Oli MW, Robinson G, Larner SF, Zhang Z, et al. Neuroproteomics and systems biology-based discovery of protein biomarkers for traumatic brain injury and clinical validation. Proteomics Clin Appl. 2008;2(10-11):1467-83.
    • (2008) Proteomics Clin Appl. , vol.2 , Issue.10-11 , pp. 1467-1483
    • Kobeissy, F.H.1    Sadasivan, S.2    Oli, M.W.3    Robinson, G.4    Larner, S.F.5    Zhang, Z.6
  • 54
    • 66049117375 scopus 로고    scopus 로고
    • Reperfusion injury after stroke: Neurovascular proteases and the blood-brain barrier
    • Ning M, Wang X, Lo EH. Reperfusion injury after stroke: neurovascular proteases and the blood-brain barrier. Handb Clin Neurol. 2008;92:117-36.
    • (2008) Handb Clin Neurol. , vol.92 , pp. 117-136
    • Ning, M.1    Wang, X.2    Lo, E.H.3
  • 55
    • 0036737795 scopus 로고    scopus 로고
    • Matrix metalloproteinases in neuroinflammation
    • Rosenberg GA. Matrix metalloproteinases in neuroinflammation. Glia. 2002;39(3):279-91.
    • (2002) Glia. , vol.39 , Issue.3 , pp. 279-291
    • Rosenberg, G.A.1
  • 56
    • 0742321910 scopus 로고    scopus 로고
    • Triggers and mediators of hemorrhagic transformation in cerebral ischemia
    • Wang X, Lo EH. Triggers and mediators of hemorrhagic transformation in cerebral ischemia. Mol Neurobiol. 2003; 28(3):229-44.
    • (2003) Mol Neurobiol. , vol.28 , Issue.3 , pp. 229-244
    • Wang, X.1    Lo, E.H.2
  • 57
    • 78649479140 scopus 로고    scopus 로고
    • Proteomic protease substrate profiling of tPA treatment in acute ischemic stroke patients: A step toward individualizing thrombolytic therapy at the bedside
    • Ning M, Sarracino DA, Buonanno FS, Krastins B, Chou S, McMullin D, et al. Proteomic protease substrate profiling of tPA treatment in acute ischemic stroke patients: a step toward individualizing thrombolytic therapy at the bedside. Transl Stroke Res. 2010;1(4):268-275.
    • (2010) Transl Stroke Res. , vol.1 , Issue.4 , pp. 268-275
    • Ning, M.1    Sarracino, D.A.2    Buonanno, F.S.3    Krastins, B.4    Chou, S.5    McMullin, D.6
  • 58
    • 77957228780 scopus 로고    scopus 로고
    • Targeted temperature management for comatose survivors of cardiac arrest
    • Holzer M. Targeted temperature management for comatose survivors of cardiac arrest. N Engl J Med. 2010;363(13):1256-64.
    • (2010) N Engl J Med. , vol.363 , Issue.13 , pp. 1256-1264
    • Holzer, M.1
  • 59
    • 58149217059 scopus 로고    scopus 로고
    • Post-cardiac arrest syndrome: Epidemiology, pathophysiology, treatment, and prognostication
    • A scientific statement from the International Liaison Committee on Resuscitation; the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; the Council on Stroke
    • Neumar R, Nolan J, Adrie C, Aibiki M, Berg RA, Böttiger BW, et al. Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication. A scientific statement from the International Liaison Committee on Resuscitation; the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; the Council on Stroke. Circulation. 2008;118(23):2452-83.
    • (2008) Circulation. , vol.118 , Issue.23 , pp. 2452-2483
    • Neumar, R.1    Nolan, J.2    Adrie, C.3    Aibiki, M.4    Berg, R.A.5    Böttiger, B.W.6
  • 61
    • 0004326079 scopus 로고    scopus 로고
    • WET. (460-375 BC). De Vetere Medicina. Hippocrates. Loeb Classical Library
    • Jones WHS WET. Hippocrates (460-375 BC). De Vetere Medicina. Hippocrates. Loeb Classical Library.
    • Hippocrates
    • Jones, W.H.S.1
  • 62
    • 1942436346 scopus 로고    scopus 로고
    • Application of therapeutic hypothermia in the ICU: Opportunities and pitfalls of a promising treatment modality. Part 1: Indications and evidence
    • Polderman KH. Application of therapeutic hypothermia in the ICU: opportunities and pitfalls of a promising treatment modality. Part 1: indications and evidence. Intensive Care Med. 2004;30(4):556-75.
    • (2004) Intensive Care Med. , vol.30 , Issue.4 , pp. 556-575
    • Polderman, K.H.1
  • 64
    • 33748684087 scopus 로고
    • Mechanism and control of centrally induced cardiac irregularities during hypothermia. I. Clinical observations
    • Pool JL, Kessler LA. Mechanism and control of centrally induced cardiac irregularities during hypothermia. I. Clinical observations. J Neurosurg. 1958;15(1):52-64.
    • (1958) J Neurosurg. , vol.15 , Issue.1 , pp. 52-64
    • Pool, J.L.1    Kessler, L.A.2
  • 65
    • 0021707433 scopus 로고
    • Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis
    • Benveniste H, Drejer J, Schousboe A, Diemer NH. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem. 1984;43(5):1369-74.
    • (1984) J Neurochem. , vol.43 , Issue.5 , pp. 1369-1374
    • Benveniste, H.1    Drejer, J.2    Schousboe, A.3    Diemer, N.H.4
  • 66
    • 0024314293 scopus 로고
    • Postischemic moderate hypothermia inhibits CA1 hippocampal ischemic neuronal injury
    • Busto R, Dietrich WD, Globus MY, Ginsberg MD. Postischemic moderate hypothermia inhibits CA1 hippocampal ischemic neuronal injury. Neurosci Lett. 1989;101(3):299-304.
    • (1989) Neurosci Lett. , vol.101 , Issue.3 , pp. 299-304
    • Busto, R.1    Dietrich, W.D.2    Globus, M.Y.3    Ginsberg, M.D.4
  • 68
    • 0025968104 scopus 로고
    • The effects of hypothermia on amino acid neurotransmitter release from the cerebral cortex
    • Simpson RE, Walter GA, Phillis JW. The effects of hypothermia on amino acid neurotransmitter release from the cerebral cortex. Neurosci Lett. 1991;124(1):83-6.
    • (1991) Neurosci Lett. , vol.124 , Issue.1 , pp. 83-86
    • Simpson, R.E.1    Walter, G.A.2    Phillis, J.W.3
  • 69
    • 0029927772 scopus 로고    scopus 로고
    • Effects of hypothermia on the rate of excitatory amino acid release after ischemic depolarization
    • Nakashima K, Todd MM. Effects of hypothermia on the rate of excitatory amino acid release after ischemic depolarization. Stroke. 1996;27(5):913-8.
    • (1996) Stroke. , vol.27 , Issue.5 , pp. 913-918
    • Nakashima, K.1    Todd, M.M.2
  • 71
    • 0032967750 scopus 로고    scopus 로고
    • Dose escalation study of the NMDA glycinesite antagonist licostinel in acute ischemic stroke
    • Albers GW, Clark WM, Atkinson RP, Madden K, Data JL, Whitehouse MJ. Dose escalation study of the NMDA glycinesite antagonist licostinel in acute ischemic stroke. Stroke. 1999;30(3):508-13.
    • (1999) Stroke. , vol.30 , Issue.3 , pp. 508-513
    • Albers, G.W.1    Clark, W.M.2    Atkinson, R.P.3    Madden, K.4    Data, J.L.5    Whitehouse, M.J.6
  • 72
    • 62849110915 scopus 로고    scopus 로고
    • Therapeutic hypothermia and controlled normothermia in the intensive care unit: Practical considerations, side effects, and cooling methods
    • Polderman K, Herold I. Therapeutic hypothermia and controlled normothermia in the intensive care unit: Practical considerations, side effects, and cooling methods. Crit Care Med. 2009;37(3):1101-20.
    • (2009) Crit Care Med. , vol.37 , Issue.3 , pp. 1101-1120
    • Polderman, K.1    Herold, I.2
  • 74
    • 78651111840 scopus 로고    scopus 로고
    • Mild hypothermia improves ischemic brain function via attenuating neuronal apoptosis
    • Li H, Wang D. Mild hypothermia improves ischemic brain function via attenuating neuronal apoptosis. Brain Res. 2011;1368:59-64.
    • (2011) Brain Res. , vol.1368 , pp. 59-64
    • Li, H.1    Wang, D.2
  • 75
    • 0032409781 scopus 로고    scopus 로고
    • Bcl-2 family proteins
    • Reed JC. Bcl-2 family proteins. Oncogene. 1998;17(25):3225-36.
    • (1998) Oncogene. , vol.17 , Issue.25 , pp. 3225-3236
    • Reed, J.C.1
  • 76
    • 79953674463 scopus 로고    scopus 로고
    • Post-ischemic hypothermia promotes generation of neural cells and reduces apoptosis by Bcl-2 in the striatum of neonatal rat brain
    • Xiong M, Cheng GQ, Ma SM, Yang Y, Shao XM, Zhou WH. Post-ischemic hypothermia promotes generation of neural cells and reduces apoptosis by Bcl-2 in the striatum of neonatal rat brain. Neurochem Int. 2011;58(6):625-33.
    • (2011) Neurochem Int. , vol.58 , Issue.6 , pp. 625-633
    • Xiong, M.1    Cheng, G.Q.2    Ma, S.M.3    Yang, Y.4    Shao, X.M.5    Zhou, W.H.6
  • 77
    • 0032893772 scopus 로고    scopus 로고
    • The tumor suppressor p53 and its response gene p21WAF1/ Cip1 are not markers of neuronal death following transient global cerebral ischemia
    • Tomasevic G, Kamme F, Stubberod P, Wieloch M, Wieloch T. The tumor suppressor p53 and its response gene p21WAF1/ Cip1 are not markers of neuronal death following transient global cerebral ischemia. Neuroscience. 1999;90(3):781-92.
    • (1999) Neuroscience. , vol.90 , Issue.3 , pp. 781-792
    • Tomasevic, G.1    Kamme, F.2    Stubberod, P.3    Wieloch, M.4    Wieloch, T.5
  • 78
    • 0036453619 scopus 로고    scopus 로고
    • Effects of mild hypothermia on superoxide anion production, superoxide dismutase expression, and activity following transient focal cerebral ischemia
    • Maier CM, Sun GH, Cheng D, Yenari MA, Chan PH, Steinberg GK. Effects of mild hypothermia on superoxide anion production, superoxide dismutase expression, and activity following transient focal cerebral ischemia. Neurobiol Dis. 2002;11(1):28-42.
    • (2002) Neurobiol Dis. , vol.11 , Issue.1 , pp. 28-42
    • Maier, C.M.1    Sun, G.H.2    Cheng, D.3    Yenari, M.A.4    Chan, P.H.5    Steinberg, G.K.6
  • 79
    • 0037474099 scopus 로고    scopus 로고
    • Hypothermia suppresses inducible nitric oxide synthase and stimulates cyclooxygenase-2 in lipopolysaccharide stimulated BV-2 cells
    • Gibbons H, Sato TA, Dragunow M. Hypothermia suppresses inducible nitric oxide synthase and stimulates cyclooxygenase-2 in lipopolysaccharide stimulated BV-2 cells. Brain Res Mol Brain Res. 2003;110(1):63-75.
    • (2003) Brain Res Mol Brain Res. , vol.110 , Issue.1 , pp. 63-75
    • Gibbons, H.1    Sato, T.A.2    Dragunow, M.3
  • 80
    • 0031048440 scopus 로고    scopus 로고
    • Protein kinase C in focal ischemic rat brain: Dual autoradiographic analysis of [14C]iodoantipyrine (IAP) and [3H]phorbol-12,13-dibutyrate (PDBu)
    • Tohyama Y, Sako K, Yonemasu Y. Protein kinase C in focal ischemic rat brain: dual autoradiographic analysis of [14C]iodoantipyrine (IAP) and [3H]phorbol-12,13-dibutyrate (PDBu). Brain Res. 1997;750(1-2):155-60.
    • (1997) Brain Res. , vol.750 , Issue.1-2 , pp. 155-160
    • Tohyama, Y.1    Sako, K.2    Yonemasu, Y.3
  • 81
    • 0036317335 scopus 로고    scopus 로고
    • Moderate hypothermia delays proinflammatory cytokine production of human peripheral blood mononuclear cells
    • Kimura A, Sakurada S, Ohkuni H, Todome Y, Kurata K. Moderate hypothermia delays proinflammatory cytokine production of human peripheral blood mononuclear cells. Crit Care Med. 2002;30(7):1499-502.
    • (2002) Crit Care Med. , vol.30 , Issue.7 , pp. 1499-1502
    • Kimura, A.1    Sakurada, S.2    Ohkuni, H.3    Todome, Y.4    Kurata, K.5
  • 82
    • 36249003722 scopus 로고    scopus 로고
    • General versus specific actions of mild-moderate hypothermia in attenuating cerebral ischemic damage
    • Zhao H, Steinberg GK, Sapolsky RM. General versus specific actions of mild-moderate hypothermia in attenuating cerebral ischemic damage. J Cereb Blood Flow Metab. 2007;27(12): 1879-94.
    • (2007) J Cereb Blood Flow Metab. , vol.27 , Issue.12 , pp. 1879-1894
    • Zhao, H.1    Steinberg, G.K.2    Sapolsky, R.M.3
  • 83
    • 17144428095 scopus 로고    scopus 로고
    • Pathophysiology of an hypoxicischemic insult during the perinatal period
    • Calvert JW, Zhang JH. Pathophysiology of an hypoxicischemic insult during the perinatal period. Neurol Res. 2005; 27(3):246-60.
    • (2005) Neurol Res. , vol.27 , Issue.3 , pp. 246-260
    • Calvert, J.W.1    Zhang, J.H.2
  • 84
    • 54049103618 scopus 로고    scopus 로고
    • Metabolic downregulation: A key to successful neuroprotection?
    • Yenari M, Kitagawa K, Lyden P, Perez-Pinzon M. Metabolic downregulation: a key to successful neuroprotection? Stroke. 2008;39(10):2910-7.
    • (2008) Stroke. , vol.39 , Issue.10 , pp. 2910-2917
    • Yenari, M.1    Kitagawa, K.2    Lyden, P.3    Perez-Pinzon, M.4
  • 85
    • 84858706456 scopus 로고    scopus 로고
    • Neuroprotective mechanisms of hypothermia in brain ischaemia
    • Yenari MA, Han HS. Neuroprotective mechanisms of hypothermia in brain ischaemia. Nat Rev Neurosci. 2012;13(4):267-78.
    • (2012) Nat Rev Neurosci. , vol.13 , Issue.4 , pp. 267-278
    • Yenari, M.A.1    Han, H.S.2
  • 86
    • 0024376263 scopus 로고
    • The importance of brain temperature in cerebral ischemic injury
    • Busto R, Dietrich WD, Globus MY, Ginsberg MD. The importance of brain temperature in cerebral ischemic injury. Stroke. 1989;20(8):1113-4.
    • (1989) Stroke. , vol.20 , Issue.8 , pp. 1113-1114
    • Busto, R.1    Dietrich, W.D.2    Globus, M.Y.3    Ginsberg, M.D.4
  • 87
    • 67149143154 scopus 로고    scopus 로고
    • Clinical application of therapeutic hypothermia in stroke
    • Liu L, Yenari MA, Ding Y. Clinical application of therapeutic hypothermia in stroke. Neurol Res. 2009;31(4):331-5.
    • (2009) Neurol Res. , vol.31 , Issue.4 , pp. 331-335
    • Liu, L.1    Yenari, M.A.2    Ding, Y.3
  • 88
    • 67650303102 scopus 로고    scopus 로고
    • Mechanisms of action, physiological effects, and complications of hypothermia
    • Polderman KH. Mechanisms of action, physiological effects, and complications of hypothermia. Crit Care Med. 2009; 37(Suppl.7):S186-202.
    • (2009) Crit Care Med. , vol.37 , Issue.SUPPL. 7
    • Polderman, K.H.1
  • 90
    • 0037148926 scopus 로고    scopus 로고
    • Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest
    • Hypothermia after Cardiac Arrest Study Group
    • Hypothermia after Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med. 2002;346(8):549-56.
    • (2002) N Engl J Med. , vol.346 , Issue.8 , pp. 549-556
  • 91
    • 0037148929 scopus 로고    scopus 로고
    • Treatment of comatose survivors of outof-hospital cardiac arrest with induced hypothermia
    • Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, Gutteridge G, et al. Treatment of comatose survivors of outof-hospital cardiac arrest with induced hypothermia. N Engl J Med. 2002;346(8):557-63.
    • (2002) N Engl J Med. , vol.346 , Issue.8 , pp. 557-563
    • Bernard, S.A.1    Gray, T.W.2    Buist, M.D.3    Jones, B.M.4    Silvester, W.5    Gutteridge, G.6
  • 92
    • 33745587304 scopus 로고    scopus 로고
    • Therapeutic hypothermia utilization among physicians after resuscitation from cardiac arrest
    • Merchant RM, Soar J, Skrifvars MB, Silfvast T, Edelson DP, Ahmad F, et al. Therapeutic hypothermia utilization among physicians after resuscitation from cardiac arrest. Crit Care Med. 2006;34(7):1935-40.
    • (2006) Crit Care Med. , vol.34 , Issue.7 , pp. 1935-1940
    • Merchant, R.M.1    Soar, J.2    Skrifvars, M.B.3    Silfvast, T.4    Edelson, D.P.5    Ahmad, F.6
  • 93
    • 84878305286 scopus 로고    scopus 로고
    • Therapeutic hypothermia after cardiac arrest remains grossly underutilized in the United States
    • (Abstract)
    • Patel P, Bleck T, Temes R, John S, Prabhakaran S. Therapeutic hypothermia after cardiac arrest remains grossly underutilized in the United States. Neurocritical Care. 2010 (Abstract).
    • (2010) Neurocritical Care.
    • Patel, P.1    Bleck, T.2    Temes, R.3    John, S.4    Prabhakaran, S.5
  • 94
    • 77950568578 scopus 로고    scopus 로고
    • Prognostication after cardiac arrest and hypothermia: A prospective study
    • Rossetti AO, Oddo M, Logroscino G, Kaplan PW. Prognostication after cardiac arrest and hypothermia: a prospective study. Ann Neurol. 2010;67(3):301-7.
    • (2010) Ann Neurol. , vol.67 , Issue.3 , pp. 301-307
    • Rossetti, A.O.1    Oddo, M.2    Logroscino, G.3    Kaplan, P.W.4
  • 95
    • 33747056622 scopus 로고    scopus 로고
    • Practice parameter: Prediction of outcome in comatose survivors after cardiopulmonary resuscitation (an evidencebased review): Report of the Quality Standards Subcommittee of the American Academy of Neurology
    • Wijdicks EF, Hijdra A, Young GB, Bassetti CL, Wiebe S. Practice parameter: prediction of outcome in comatose survivors after cardiopulmonary resuscitation (an evidencebased review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2006;67(2):203-10.
    • (2006) Neurology. , vol.67 , Issue.2 , pp. 203-210
    • Wijdicks, E.F.1    Hijdra, A.2    Young, G.B.3    Bassetti, C.L.4    Wiebe, S.5
  • 96
    • 78650782390 scopus 로고    scopus 로고
    • S-100B is superior to NSE, BDNF and GFAP in predicting outcome of resuscitation from cardiac arrest with hypothermia treatment
    • Mortberg E, Zetterberg H, Nordmark J, Blennow K, Rosengren L, Rubertsson S. S-100B is superior to NSE, BDNF and GFAP in predicting outcome of resuscitation from cardiac arrest with hypothermia treatment. Resuscitation. 2010;82(1):26-31.
    • (2010) Resuscitation. , vol.82 , Issue.1 , pp. 26-31
    • Mortberg, E.1    Zetterberg, H.2    Nordmark, J.3    Blennow, K.4    Rosengren, L.5    Rubertsson, S.6
  • 97
    • 56149111230 scopus 로고    scopus 로고
    • A thromboelastometric evaluation of the effects of hypothermia on the coagulation system
    • Rundgren M, Engstrom M. A thromboelastometric evaluation of the effects of hypothermia on the coagulation system. Anesth Analg. 2008;107(5):1465-8.
    • (2008) Anesth Analg. , vol.107 , Issue.5 , pp. 1465-1468
    • Rundgren, M.1    Engstrom, M.2
  • 98
    • 61849115201 scopus 로고    scopus 로고
    • Identification of N-glycosylation sites on secreted proteins of human hepatocellular carcinoma cells with a complementary proteomics approach
    • Cao J, Shen C, Wang H, Shen H, Chen Y, Nie A, et al. Identification of N-glycosylation sites on secreted proteins of human hepatocellular carcinoma cells with a complementary proteomics approach. J Proteome Res. 2009;8(2):662-72.
    • (2009) J Proteome Res. , vol.8 , Issue.2 , pp. 662-672
    • Cao, J.1    Shen, C.2    Wang, H.3    Shen, H.4    Chen, Y.5    Nie, A.6
  • 100
    • 84878268351 scopus 로고    scopus 로고
    • Studying extracellular signaling utilizing a glycoproteomic approach-Lectin blot surveys-A first and important step
    • Cao J, Guo S, Arai K, Lo EH, Ning MM. Studying extracellular signaling utilizing a glycoproteomic approach-Lectin blot surveys-A first and important step. Methods in Molecular Biology 2013;1013:227-33.
    • (2013) Methods in Molecular Biology , vol.1013 , pp. 227-233
    • Cao, J.1    Guo, S.2    Arai, K.3    Lo, E.H.4    Ning, M.M.5
  • 101
    • 27444441375 scopus 로고    scopus 로고
    • Patent foramen ovale: Current pathology, pathophysiology, and clinical status
    • Hara H, Virmani R, Ladich E, Mackey-Bojack S, Titus J, Reisman et al. Patent foramen ovale: current pathology, pathophysiology, and clinical status. J Am Coll Cardiol. 2005;46(9):1768-76.
    • (2005) J Am Coll Cardiol. , vol.46 , Issue.9 , pp. 1768-1776
    • Hara, H.1    Virmani, R.2    Ladich, E.3    McKey-Bojack, S.4    Titus, J.5    Reisman6
  • 102
    • 0031440089 scopus 로고    scopus 로고
    • Subtypes of ischemic stroke. A hospital-based stroke registry in Taiwan (SCAN-IV)
    • Yip PK, Jeng JS, Lee TK, Chang YC, Huang ZS, Ng SK, et al. Subtypes of ischemic stroke. A hospital-based stroke registry in Taiwan (SCAN-IV). Stroke. 1997;28(12):2507-12.
    • (1997) Stroke. , vol.28 , Issue.12 , pp. 2507-2512
    • Yip, P.K.1    Jeng, J.S.2    Lee, T.K.3    Chang, Y.C.4    Huang, Z.S.5    Ng, S.K.6
  • 103
    • 38049036337 scopus 로고    scopus 로고
    • Patent foramen ovale-'back door' to the brain, even in kids
    • Latson LA. Patent foramen ovale-'back door' to the brain, even in kids. Catheter Cardiovasc Interv. 2007;70(7):1008-9.
    • (2007) Catheter Cardiovasc Interv. , vol.70 , Issue.7 , pp. 1008-1009
    • Latson, L.A.1
  • 105
    • 60449094498 scopus 로고    scopus 로고
    • Heart disease and stroke statistics-2009 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
    • Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, et al. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009;119(3):e21-181.
    • (2009) Circulation. , vol.119 , Issue.3
    • Lloyd-Jones, D.1    Adams, R.2    Carnethon, M.3    de Simone, G.4    Ferguson, T.B.5    Flegal, K.6
  • 107
    • 28244472771 scopus 로고    scopus 로고
    • Clinical practice. Patent foramen ovale in young adults with unexplained stroke
    • Kizer JR, Devereux RB. Clinical practice. Patent foramen ovale in young adults with unexplained stroke. N Engl J Med. 2005;353(22):2361-72.
    • (2005) N Engl J Med. , vol.353 , Issue.22 , pp. 2361-2372
    • Kizer, J.R.1    Devereux, R.B.2
  • 108
    • 0021352808 scopus 로고
    • Incidence and size of patent foramen ovale during the first 10 decades of life: An autopsy study of 965 normal hearts
    • Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc. 1984;59(1):17-20.
    • (1984) Mayo Clin Proc. , vol.59 , Issue.1 , pp. 17-20
    • Hagen, P.T.1    Scholz, D.G.2    Edwards, W.D.3
  • 109
    • 0032824348 scopus 로고    scopus 로고
    • Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: The SPARC study. Stroke prevention: Assessment of risk in a community
    • Meissner I, Whisnant JP, Khandheria BK, Spittell PC, O'Fallon WM, Pascoe RD, et al. Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: the SPARC study. Stroke prevention: assessment of risk in a community. Mayo Clin Proc. 1999;74(9):862-9.
    • (1999) Mayo Clin Proc. , vol.74 , Issue.9 , pp. 862-869
    • Meissner, I.1    Whisnant, J.P.2    Khandheria, B.K.3    Spittell, P.C.4    O'Fallon, W.M.5    Pascoe, R.D.6
  • 110
    • 15844399772 scopus 로고    scopus 로고
    • When and how to diagnose patent foramen ovale
    • Pinto FJ. When and how to diagnose patent foramen ovale. Heart. 2005;91(4):438-40.
    • (2005) Heart. , vol.91 , Issue.4 , pp. 438-440
    • Pinto, F.J.1
  • 111
    • 57149144661 scopus 로고    scopus 로고
    • Is closure recommended for patent foramen ovale and cryptogenic stroke? Patent foramen ovale in cryptogenic stroke: Not to close
    • Messe SR, Kasner SE. Is closure recommended for patent foramen ovale and cryptogenic stroke? Patent foramen ovale in cryptogenic stroke: not to close. Circulation. 2008; 118(19):1999-2004.
    • (2008) Circulation. , vol.118 , Issue.19 , pp. 1999-2004
    • Messe, S.R.1    Kasner, S.E.2
  • 112
    • 57149126079 scopus 로고    scopus 로고
    • Is closure recommended for patent foramen ovale and cryptogenic stroke? Patent foramen ovale and cryptogenic stroke: To close or not to close?
    • Windecker S, Meier B. Is closure recommended for patent foramen ovale and cryptogenic stroke? Patent foramen ovale and cryptogenic stroke: to close or not to close? Closure: what else! Circulation. 2008;118(19):1989-98.
    • (2008) Closure: What else! Circulation. , vol.118 , Issue.19 , pp. 1989-1998
    • Windecker, S.1    Meier, B.2
  • 113
    • 0030966603 scopus 로고    scopus 로고
    • Treatment of patent foramen ovale and stroke: To close or not to close, that is not yet the question
    • Sacco RL, Di Tullio MR, Homma S. Treatment of patent foramen ovale and stroke: to close or not to close, that is not yet the question. Eur Neurol. 1997;37(4):205-6.
    • (1997) Eur Neurol. , vol.37 , Issue.4 , pp. 205-206
    • Sacco, R.L.1    Di Tullio, M.R.2    Homma, S.3
  • 115
    • 1442274764 scopus 로고    scopus 로고
    • Patent foramen ovale and recurrent stroke: Closure is the best option: No
    • Tong DC, Becker KJ. Patent foramen ovale and recurrent stroke: closure is the best option: no. Stroke. 2004;35(3):804-5.
    • (2004) Stroke. , vol.35 , Issue.3 , pp. 804-805
    • Tong, D.C.1    Becker, K.J.2
  • 116
    • 1442323790 scopus 로고    scopus 로고
    • Patent foramen ovale and recurrent stroke: Closure is the best option: Yes
    • Furlan AJ. Patent foramen ovale and recurrent stroke: closure is the best option: yes. Stroke. 2004;35(3):803-4.
    • (2004) Stroke. , vol.35 , Issue.3 , pp. 803-804
    • Furlan, A.J.1
  • 117
    • 1442323794 scopus 로고    scopus 로고
    • Patent foramen ovale and stroke: Closure by further randomized trial is required!
    • Donnan GA, Davis SM. Patent foramen ovale and stroke: closure by further randomized trial is required! Stroke. 2004;35(3):806.
    • (2004) Stroke. , vol.35 , Issue.3 , pp. 806
    • Donnan, G.A.1    Davis, S.M.2
  • 118
    • 34249855253 scopus 로고    scopus 로고
    • Patent foramen ovale and stroke: To close or not to close?
    • Furlan AJ. Patent foramen ovale and stroke: to close or not to close? Cleve Clin J Med. 2007;74(Suppl.1):S118-20.
    • (2007) Cleve Clin J Med. , vol.74 , Issue.SUPPL. 1
    • Furlan, A.J.1
  • 120
    • 84858265970 scopus 로고    scopus 로고
    • Closure or medical therapy for cryptogenic stroke with patent foramen ovale
    • Furlan AJ, Reisman M, Massaro J, Mauri L, Adams H, Albers GW, et al. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med. 2012; 366(11):991-9.
    • (2012) N Engl J Med. , vol.366 , Issue.11 , pp. 991-999
    • Furlan, A.J.1    Reisman, M.2    Massaro, J.3    Mauri, L.4    Adams, H.5    Albers, G.W.6
  • 121
    • 0038504294 scopus 로고    scopus 로고
    • Patent foramen ovale and hypercoagulability as combined risk factors for stroke
    • Florez JC, Ay H, Van Cott EM, Buonanno FS. Patent foramen ovale and hypercoagulability as combined risk factors for stroke. J Stroke Cerebrovasc Dis. 2003;12(3):114-8.
    • (2003) J Stroke Cerebrovasc Dis. , vol.12 , Issue.3 , pp. 114-118
    • Florez, J.C.1    Ay, H.2    van Cott, E.M.3    Buonanno, F.S.4
  • 122
    • 0037227159 scopus 로고    scopus 로고
    • Inherited thrombophilic disorders in young adults with ischemic stroke and patent foramen ovale
    • Pezzini A, Del Zotto E, Magoni M, Costa A, Archetti S, Grassi M, et al. Inherited thrombophilic disorders in young adults with ischemic stroke and patent foramen ovale. Stroke. 2003;34:28-33.
    • (2003) Stroke. , vol.34 , pp. 28-33
    • Pezzini, A.1    Del Zotto, E.2    Magoni, M.3    Costa, A.4    Archetti, S.5    Grassi, M.6
  • 124
    • 84871432184 scopus 로고    scopus 로고
    • Heart-brain signaling in Patent Foramen Ovale related stroke: Differential Plasma Protein Expression Patterns Revealed with a Two-Pass LC-MS/MS Discovery Workflow
    • Lopez MF, Sarracino D, Vogelsang M, Sutton JN, Athanas M, Krastins B, Ning MM, et al. Heart-brain signaling in Patent Foramen Ovale related stroke: Differential Plasma Protein Expression Patterns Revealed with a Two-Pass LC-MS/MS Discovery Workflow. Journal of Investigative Medicine. 2012;60(8):1122-30.
    • (2012) Journal of Investigative Medicine. , vol.60 , Issue.8 , pp. 1122-1130
    • Lopez, M.F.1    Sarracino, D.2    Vogelsang, M.3    Sutton, J.N.4    Athanas, M.5    Krastins, B.6    Ning, M.M.7
  • 127
    • 0029918933 scopus 로고    scopus 로고
    • Two-dimensional gel electrophoresis of Escherichia coli homogenates: The Escherichia coli SWISS-2DPAGE database
    • Pasquali C, Frutiger S, Wilkins MR, Hughes GJ, Appel RD, Bairoch A, et al. Two-dimensional gel electrophoresis of Escherichia coli homogenates: the Escherichia coli SWISS-2DPAGE database. Electrophoresis. 1996;17(3):547-55.
    • (1996) Electrophoresis. , vol.17 , Issue.3 , pp. 547-555
    • Pasquali, C.1    Frutiger, S.2    Wilkins, M.R.3    Hughes, G.J.4    Appel, R.D.5    Bairoch, A.6
  • 128
    • 0031848226 scopus 로고    scopus 로고
    • Proteome and proteomics: New technologies, new concepts, and new words
    • Anderson NL, Anderson NG. Proteome and proteomics: new technologies, new concepts, and new words. Electrophoresis. 1998;19(11):1853-61.
    • (1998) Electrophoresis. , vol.19 , Issue.11 , pp. 1853-1861
    • Anderson, N.L.1    Anderson, N.G.2
  • 129
    • 0032784646 scopus 로고    scopus 로고
    • Proteomics: Quantitative and physical mapping of cellular proteins
    • Blackstock WP, Weir MP. Proteomics: quantitative and physical mapping of cellular proteins. Trends Biotechnol. 1999;17(3):121-7.
    • (1999) Trends Biotechnol. , vol.17 , Issue.3 , pp. 121-127
    • Blackstock, W.P.1    Weir, M.P.2
  • 130
    • 0032707568 scopus 로고    scopus 로고
    • Incidence rates of first-ever ischemic stroke subtypes among blacks: A population-based study
    • Woo D, Gebel J, Miller R, Kothari R, Brott T, Khoury J, et al. Incidence rates of first-ever ischemic stroke subtypes among blacks: a population-based study. Stroke. 1999; 30(12):2517-22.
    • (1999) Stroke. , vol.30 , Issue.12 , pp. 2517-2522
    • Woo, D.1    Gebel, J.2    Miller, R.3    Kothari, R.4    Brott, T.5    Khoury, J.6
  • 131
    • 0036025352 scopus 로고    scopus 로고
    • Experimental models in focal cerebral ischemia: Are we there yet?
    • Leker RR, Constantini S. Experimental models in focal cerebral ischemia: are we there yet? ActaNeurochir Suppl. 2002;83:55-9.
    • (2002) ActaNeurochir Suppl. , vol.83 , pp. 55-59
    • Leker, R.R.1    Constantini, S.2
  • 133
    • 0001644020 scopus 로고    scopus 로고
    • The human plasma proteome: History, character, and diagnostic prospects
    • Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics. 2002;1(11):845-67.
    • (2002) Mol Cell Proteomics. , vol.1 , Issue.11 , pp. 845-867
    • Anderson, N.L.1    Anderson, N.G.2
  • 134
    • 19944408971 scopus 로고    scopus 로고
    • Limitations of current proteomics technologies
    • Garbis S, Lubec G, Fountoulakis M. Limitations of current proteomics technologies. J Chromatogr A. 2005;1077(1):1-18.
    • (2005) J Chromatogr A. , vol.1077 , Issue.1 , pp. 1-18
    • Garbis, S.1    Lubec, G.2    Fountoulakis, M.3
  • 135
    • 3042690586 scopus 로고    scopus 로고
    • Ischemic stroke subtypes: A population-based study of incidence rates among blacks and whites
    • Schneider AT, Kissela B, Woo D, Kleindorfer D, Alwell K, Miller R, et al. Ischemic stroke subtypes: a population-based study of incidence rates among blacks and whites. Stroke. 2004;35(7):1552-6.
    • (2004) Stroke. , vol.35 , Issue.7 , pp. 1552-1556
    • Schneider, A.T.1    Kissela, B.2    Woo, D.3    Kleindorfer, D.4    Alwell, K.5    Miller, R.6
  • 136
    • 0035164329 scopus 로고    scopus 로고
    • Risk factors, outcome, and treatment in subtypes of ischemic stroke: The German stroke data bank
    • Grau AJ, Weimar C, Buggle F, Heinrich A, Goertler M, Neumaier S, et al. Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank. Stroke. 2001;32(11):2559-66.
    • (2001) Stroke. , vol.32 , Issue.11 , pp. 2559-2566
    • Grau, A.J.1    Weimar, C.2    Buggle, F.3    Heinrich, A.4    Goertler, M.5    Neumaier, S.6
  • 137
    • 0036901467 scopus 로고    scopus 로고
    • Stroke in the young in the northern Manhattan stroke study
    • Jacobs BS, Boden-Albala B, Lin IF, Sacco RL. Stroke in the young in the northern Manhattan stroke study. Stroke. 2002;33(12):2789-93.
    • (2002) Stroke. , vol.33 , Issue.12 , pp. 2789-2793
    • Jacobs, B.S.1    Boden-Albala, B.2    Lin, I.F.3    Sacco, R.L.4
  • 138


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.